Download PDF
1 / Pages

Other users also viewed these articles

cccDNA epigenetic regulator as target for therapeutical vaccine development against hepatitis B Patricia Gita Naully; Marselina Irasonia Tan; Agustiningsih Agustiningsih; Caecilia Sukowati; Ernawati Arifin Giri-Rachman;
10.1016/j.aohep.2024.101533
Prevalence of occult hepatitis B virus infection and characterisation of hepatitis B surface antigen mutants among adults in western Croatia Marina Bubonja-¿onje; Dolores Peru¿; Maja Abram; Bojana Mohar-Vitezi¿;
Ann Hepatol. 2024;29:
Improved bone and renal safety in younger tenofovir disoproxil fumarate experienced chronic hepatitis B patients after switching to tenofovir alafenamide or entecavir Fa- Da Wang; Jing Zhou; Lan-Qing Li; Yu-Jing Li; Meng-Lan Wang; Ya-Chao Tao; Dong-Mei Zhang; Yong-Hong Wang; En-Qiang Chen;
Ann Hepatol. 2023;28: